Why BeOne Medicines AG (ONC) stock moved
BeOne Medicines AG (ONC) shares rose 4.5% to $394.68 as of November 5, 2026, a moderate gain from the prior close of $377.78. BestStocks flagged the session as a major change for ONC. The move is tied to an earnings beat. Below, we break down what changed for ONC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Earnings Beat
BeOne Medicines AG (ONC) reported EPS of $4.59 vs. $1.90 consensus estimate for Q3 FY2026, beating by 141.6%. BeOne Medicines AG earnings announcement scheduled for 2027-02-25.
What it means for BeOne Medicines AG investors
For BeOne Medicines AG investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Positive 4.5% session move. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $407.00, implying +3.1% upside from $394.68. BestStocks rates the overall signal quality medium (71/100). With earnings roughly 112 days out, the next report is the most likely near-term test of the move.
ONC price reaction
ONC last traded at $394.68, up $16.90 (+4.47%) from the previous close of $377.78. The session traded on 1.0× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $349.08 and $394.68, and it currently sits about 100% of the way up that band.
Bullish and bearish analyst opinions on BeOne Medicines AG (ONC)
The consensus analyst price target on BeOne Medicines AG (ONC) is $407.00, 3.1% above the recent $394.68. Over the past 90 days analysts logged 0 upgrades, 4 maintains, and 0 downgrades. Here is how the bullish and bearish cases on ONC line up.
The bullish case
- Wall Street's consensus price target of $407.00 implies +3.1% upside from $394.68.
- The Street's most bullish target is $459.00 (+16.3%).
- Earnings beat with positive market reaction.
- Positive 4.5% session move.
- Positive price momentum.
The bearish case
- The most bearish analyst target is $367.00 (-7.0%).
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 5, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ONC
In-depth ONC event analyses
Frequently asked questions about ONC
Why did BeOne Medicines AG (ONC) stock move?
ONC rose 4.5% to $394.68. The move is associated with an earnings beat.
How much did ONC stock rise?
ONC gained 4.47% ($16.90) versus the prior close of $377.78, last trading at $394.68 on 1.0× average volume.
When is BeOne Medicines AG's next earnings date?
ONC's next earnings report is estimated for 2027-02-25 — about 112 days away.
What is the analyst price target for ONC?
The consensus analyst price target for ONC is $407.00, about 3.1% above the current $394.68. Over the past 90 days, analysts recorded 0 upgrades, 4 maintains, and 0 downgrades.
How BestStocks tracks ONC
This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 20 tracked change events for ONC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 5, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.